Location History:
- Gentilly, FR (1976 - 1977)
- Bourge la Reine, FR (1982)
- Bourg-la-Reine, FR (1981 - 2013)
- Paris, FR (2011 - 2013)
Company Filing History:
11 out of 252 
7 out of 389 
4 out of 73 
Years Active: 1976-2013
Title: Innovations by Patrick Andre Lardenois: A Look into His Patents and Contributions
Introduction
Patrick Andre Lardenois, based in Gentilly, France, has made significant contributions to the field of pharmaceuticals, holding a remarkable total of 21 patents. His innovative work focuses on developing therapeutic compounds that address various health challenges.
Latest Patents
Among his latest patents, one noteworthy invention is the "1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives." This patent details compounds with a general formula defined in the disclosure, highlighting their potential in a wide range of therapeutic applications. Another significant patent covers "Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives," which discusses compounds along with their therapeutic uses and the synthesis processes involved.
Career Highlights
Throughout his career, Patrick has worked with esteemed companies such as Synthelabo and Sanofi-Aventis. His roles in these organizations allowed him to leverage his expertise in research and development, leading to several groundbreaking inventions that advance medical science.
Collaborations
Patrick has collaborated with notable professionals in his field, including Jonathan Reid Frost and Alistair Lochead. These partnerships have further enriched his research endeavors, allowing for the exchange of ideas and the development of innovative solutions to complex medical challenges.
Conclusion
Patrick Andre Lardenois's contributions through his 21 patents exemplify his dedication to advancing pharmaceutical science. His latest inventions not only showcase his innovative spirit but also highlight the collaborative nature of research in the quest for better therapeutic applications.